重组小鼠IgG B2

Recombinant mouse IgG is a novel, sustainable replacement to serum-derived mouse IgG, providing manufacturers and researchers a tightly-controlled, non-animal-derived blocking solution to efficiently reduce nonspecific antibody interference in diagnostic assays while improving lot reproducibility and test accuracy, yet simplifying import regulations.
The recombinant mouse IgG is offered in two unique blends providing different formulations to select from and optimize for best performance results within a specific immunoassay. The formulas are designed to deliver equivalent or better blocking efficiency compared to serum-derived mouse IgG. This B2 recombinant mouse IgG was developed within a similar formulation as B1 but with directed blocking capability to specifically bind human anti-mouse antibodies present in serum/plasma samples and reduce non-specific binding in an immunoassay system using capture and detection antibodies.  In certain protocols, this directed binding may result in a lower concentration requirement as compared with standard serum-derived mouse IgG.